Q

Pharmaceutical Co-crystals for improving drug performance Assignment Help

Pharmaceutical Co-crystals for improving drug performance Assignment Help - Hire skilled tutor for Pharmaceutical Co-crystals for improving drug performance Assignment Help Service!!
Previous << >> Next

HIRE PROFESSIONAL WRITER FROM MIRACLESKILLS.COM AND GET BEST QUALITY PHARMACEUTICAL CO-CRYSTALS FOR IMPROVING DRUG PERFORMANCE ASSIGNMENT HELP AND ASSESSMENT WRITING SERVICES!

Title: Pharmaceutical Co-crystals for improving drug performance

In the current course work explain what pharmaceutical co-crystals are including the following aspects:

- advantages of co-crystals compared to the bulk API

- how the selection of the drug-conformer pair is done

- discuss 3-4 main synthesis methods

- provide three case studies for the formation of co-crystals and discuss the properties of the synthesised compounds

- provide a brief discussion from a regulatory point of view

Deal with endless assignments without any hassle by getting the support of experienced professionals from the best online Diploma assignment help in the UK.

Pharmaceutical co-crystals are multicomponent crystalline solids in which at least one component is an active pharmaceutical ingredient (API). Co-crystals are formed by non-covalent interactions, such as hydrogen bonds, π-π stacking, and electrostatic forces, between the API and a coformer, which is typically a pharmaceutically acceptable ingredient, such as an amino acid, organic acid, or carbohydrate.

Co-crystallization is a promising approach to improve the performance of pharmaceutical drugs by modifying their physicochemical properties, such as solubility, dissolution rate, hygroscopicity, and stability. For example, co-crystallization can be used to:

Increase the solubility of poorly soluble drugs, leading to improved bioavailability and efficacy.
Improve the dissolution rate of drugs, leading to faster onset of action.
Reduce the hygroscopicity of drugs, making them more stable in humid environments.
Improve the physical stability of drugs, making them less likely to degrade over time.

Co-crystals can also be used to modify other properties of drugs, such as their taste, odor, and melting point. This can make drugs more palatable to patients and easier to formulate into dosage forms.

Co-crystallization is a relatively new technology, but it has the potential to significantly improve the performance of many pharmaceutical drugs. A number of co-crystals are currently in clinical development or have already been approved for marketing.

Here are some examples of how pharmaceutical co-crystals have been used to improve drug performance:

Carbamazepine: Carbamazepine is a poorly soluble anticonvulsant drug. Co-crystallization of carbamazepine with saccharin has been shown to increase its solubility by up to 10-fold.
Griseofulvin: Griseofulvin is an antifungal drug with a slow dissolution rate. Co-crystallization of griseofulvin with pyridone has been shown to increase its dissolution rate by up to 100-fold.
Ritonavir: Ritonavir is an antiretroviral drug with low oral bioavailability. Co-crystallization of ritonavir with lopinavir has been shown to increase its oral bioavailability by up to 30%.

These are just a few examples of how pharmaceutical co-crystals can be used to improve drug performance. As research in this area continues, we can expect to see even more innovative and effective co-crystal-based drugs in the future.

GET READYMADE PHARMACEUTICAL CO-CRYSTALS FOR IMPROVING DRUG PERFORMANCE ASSIGNMENT SOLUTIONS - 100% PLAGIARISM FREE WORK DOCUMENT AT NOMINAL CHARGES!

Want to Excel in Course? Hire Trusted Writers for Help! —> https://miracleskills.com/

Lists of comments

Leave a comment


Captcha